Letoha T - Search Results

1

The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology.

Hudák A, Jósvay K, Domonkos I, Letoha A, Szilák L, Letoha T. Hudák A, et al. Among authors: letoha t. Int J Mol Sci. 2021 Jun 30;22(13):7070. doi: 10.3390/ijms22137070. Int J Mol Sci. 2021. PMID: 34209175 Free PMC article.

2

Anti-calmodulins and tricyclic adjuvants in pain therapy block the TRPV1 channel.

Oláh Z, Jósvay K, Pecze L, Letoha T, Babai N, Budai D, Otvös F, Szalma S, Vizler C. Oláh Z, et al. Among authors: letoha t. PLoS One. 2007 Jun 20;2(6):e545. doi: 10.1371/journal.pone.0000545. PLoS One. 2007. PMID: 17579717 Free PMC article.

3

Human keratinocytes are vanilloid resistant.

Pecze L, Szabó K, Széll M, Jósvay K, Kaszás K, Kúsz E, Letoha T, Prorok J, Koncz I, Tóth A, Kemény L, Vizler C, Oláh Z. Pecze L, et al. Among authors: letoha t. PLoS One. 2008;3(10):e3419. doi: 10.1371/journal.pone.0003419. Epub 2008 Oct 14. PLoS One. 2008. PMID: 18852901 Free PMC article.

4

Cell-penetrating peptide exploited syndecans.

Letoha T, Keller-Pintér A, Kusz E, Kolozsi C, Bozsó Z, Tóth G, Vizler C, Oláh Z, Szilák L. Letoha T, et al. Biochim Biophys Acta. 2010 Dec;1798(12):2258-65. doi: 10.1016/j.bbamem.2010.01.022. Epub 2010 Feb 2. Biochim Biophys Acta. 2010. PMID: 20138023 Free article.

5

Divalent heavy metal cations block the TRPV1 Ca(2+) channel.

Pecze L, Winter Z, Jósvay K, Ötvös F, Kolozsi C, Vizler C, Budai D, Letoha T, Dombi G, Szakonyi G, Oláh Z. Pecze L, et al. Among authors: letoha t. Biol Trace Elem Res. 2013 Mar;151(3):451-61. doi: 10.1007/s12011-012-9570-y. Epub 2012 Dec 21. Biol Trace Elem Res. 2013. PMID: 23264033 Free PMC article.

6

Contribution of syndecans to lipoplex-mediated gene delivery.

Letoha T, Kolozsi C, Ekes C, Keller-pintér A, Kusz E, Szakonyi G, Duda E, Szilák L. Letoha T, et al. Eur J Pharm Sci. 2013 Jul 16;49(4):550-5. doi: 10.1016/j.ejps.2013.05.022. Epub 2013 Jun 1. Eur J Pharm Sci. 2013. PMID: 23732629

7

What is the potential of syndecan-4-targeted novel delivery technologies?

Szilak L, Letoha T, Ughy B. Szilak L, et al. Among authors: letoha t. Ther Deliv. 2013 Dec;4(12):1479-81. doi: 10.4155/tde.13.112. Ther Deliv. 2013. PMID: 24304244 No abstract available.

8

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner.

Keller-Pinter A, Ughy B, Domoki M, Pettko-Szandtner A, Letoha T, Tovari J, Timar J, Szilak L. Keller-Pinter A, et al. Among authors: letoha t. PLoS One. 2017 Nov 9;12(11):e0187094. doi: 10.1371/journal.pone.0187094. eCollection 2017. PLoS One. 2017. PMID: 29121646 Free PMC article.

9

Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1-42).

Letoha T, Hudák A, Kusz E, Pettkó-Szandtner A, Domonkos I, Jósvay K, Hofmann-Apitius M, Szilák L. Letoha T, et al. Sci Rep. 2019 Feb 4;9(1):1393. doi: 10.1038/s41598-018-37476-9. Sci Rep. 2019. PMID: 30718543 Free PMC article.

10

Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau.

Hudák A, Kusz E, Domonkos I, Jósvay K, Kodamullil AT, Szilák L, Hofmann-Apitius M, Letoha T. Hudák A, et al. Among authors: letoha t. Sci Rep. 2019 Nov 12;9(1):16543. doi: 10.1038/s41598-019-53038-z. Sci Rep. 2019. PMID: 31719623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page